See how well you fit this role
Get an instant score, plus where you shine and where you'd need to stretch, so you know if it's worth the application.
?
/100
Roche’s License to Operate graduate programme offers rotations across quality, patient safety, regulatory affairs, clinical operations and medical information to support compliant pharmaceutical operations.
The Position
We aspire to be a leading edge License to Operate (LTO) organisation that drives compliance, quality, and innovative patient-centric solutions, utilising cross-functional expertise across Roche UK to support delivering on our mission and business operations. We strive to create a workplace where team members own their development and learning and are empowered to create and innovate.
The Opportunity
This is an excellent opportunity for an individual who has recently graduated with a science background. The role is a rotational programme with the opportunity to work across five sections within the Roche UK License to Operate (LTO) department: Quality, Patient Safety, Regulatory, Medical Clinical Operations, and Medical Information. The programme will run for 2 years, allowing you to spend time in multiple sections to drive cross-functional improvement. Expected start date of the programme is January 2027.
Background of each LTO Section
Quality: Responsible for the administration and operational management of key GxP Quality Management System (QMS) processes and supporting the Local Quality Responsible (LQR) and Qualified Persons (QP) to fulfill company and legal obligations.
Regulatory: Translates the constantly evolving requirements of the UK Regulatory environment into Roche policies, procedures, solutions, and strategies that ensure compliance and maximize value for patients.
Patient Safety: Ensures safety information is collected and recorded accurately to a high standard, actively partnering with the business across activities such as Non-Interventional Studies (NIS), digital activities, market research, and patient support programmes.
Medical Clinical Operations (MCO): Provides clinical operations expertise in managing funded interventional and non-interventional studies, managed non-interventional studies, and pre-approval access programs, working across the business and externally with trial sites.
Medical Information: Contributes to the safe and effective use of Roche medicines by responding to scientific, technical, and medical enquiries from healthcare professionals (HCPs), patients, and members of the public.
Who you are:
Applicants should have a recent science degree of 2:1 or above and a strong desire to engage and drive cross-functional improvement.
To be successful in this opportunity, applicants should also have:
Excellent computer & digital skills
Ability to work reliably and flexibly
Strong communication and analytical skills
Ability to work independently and within a team, developing effective working relationships with a wide range of colleagues
How to apply
Apply directly through the company website. Clicking the link below will open the application page in a new window.

Location: Switzerland
Industry: Pharmaceuticals
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
STAY IN
THE KN

W
No spam, just the latest roles and career advice delivered straight to your inbox.
© Gradworx 2026